Clinical trial
An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in…
NCT00189930 · Bavarian Nordic, Industry · Completed
Key facts
| NCT number | NCT00189930 |
|---|---|
| Title | An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients |
| Official title | A Single-blind, Randomized, Controlled, Phase II Study to Evaluate Immunogenicity and Safety of Two Doses of the MVA-nef HIV Vaccine in HIV-1 Infected Patients With CD4 > 250/µl |
| Lead sponsor | Bavarian Nordic, Industry |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Biological |
| Interventions | MVA-nef, IMVAMUNE |
| Enrollment | 77 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 1, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: